{
    "Trade/Device Name(s)": [
        "cobas\u00ae CT/NG for use on cobas\u00ae 6800/8800 systems"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K173887",
    "Predicate Device Reference 510(k) Number(s)": [
        "K163184"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSL",
        "MKZ",
        "OOI"
    ],
    "Summary Letter Date": "December 20, 2017",
    "Summary Letter Received Date": "December 21, 2017",
    "Submission Date": "December 4, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.3390",
        "21 CFR 866.3120",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Neisseria spp. direct serological test reagents",
        "Chlamydia serological reagents",
        "Real Time Nucleic Acid Amplification System"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Chlamydia trachomatis (CT)",
        "Neisseria gonorrhoeae (NG)"
    ],
    "Specimen Type(s)": [
        "Male urine",
        "Female urine",
        "Clinician-instructed self-collected vaginal swab",
        "Clinician-collected vaginal swab",
        "Endocervical swab",
        "Cervical specimen"
    ],
    "Specimen Container(s)": [
        "cobas\u00ae PCR Media",
        "PreservCyt\u00ae solution"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas\u00ae 6800 system",
        "cobas\u00ae 8800 system"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Nucleic acid extraction and purification",
        "Automated sample preparation"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Qualitative in vitro diagnostic PCR"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Collection kit",
        "Sample preparation"
    ],
    "Document Summary": "FDA 510(k) summary for cobas CT/NG qualitative in vitro PCR assay for direct detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA on cobas 6800/8800 systems",
    "Indications for Use Summary": "Automated, qualitative in vitro nucleic acid PCR test for direct detection of Chlamydia trachomatis and/or Neisseria gonorrhoeae DNA in urine, vaginal, endocervical, and cervical specimens, aiding diagnosis of chlamydial and gonococcal disease in symptomatic and asymptomatic individuals",
    "fda_folder": "Microbiology"
}